Lo MK - Search Results

1

Single-dose mucosal replicon-particle vaccine protects against lethal Nipah virus infection up to 3 days after vaccination.

Welch SR, Spengler JR, Genzer SC, Coleman-McCray JD, Harmon JR, Sorvillo TE, Scholte FEM, Rodriguez SE, O'Neal TJ, Ritter JM, Ficarra G, Davies KA, Kainulainen MH, Karaaslan E, Bergeron É, Goldsmith CS, Lo MK, Nichol ST, Montgomery JM, Spiropoulou CF. Welch SR, et al. Among authors: lo mk. Sci Adv. 2023 Aug 4;9(31):eadh4057. doi: 10.1126/sciadv.adh4057. Epub 2023 Aug 4. Sci Adv. 2023. PMID: 37540755 Free PMC article.

2

The C, V and W proteins of Nipah virus inhibit minigenome replication.

Sleeman K, Bankamp B, Hummel KB, Lo MK, Bellini WJ, Rota PA. Sleeman K, et al. Among authors: lo mk. J Gen Virol. 2008 May;89(Pt 5):1300-1308. doi: 10.1099/vir.0.83582-0. J Gen Virol. 2008. PMID: 18420809

3

The emergence of Nipah virus, a highly pathogenic paramyxovirus.

Lo MK, Rota PA. Lo MK, et al. J Clin Virol. 2008 Dec;43(4):396-400. doi: 10.1016/j.jcv.2008.08.007. Epub 2008 Oct 2. J Clin Virol. 2008. PMID: 18835214 Review.

4

Development of a neutralization assay for Nipah virus using pseudotype particles.

Tamin A, Harcourt BH, Lo MK, Roth JA, Wolf MC, Lee B, Weingartl H, Audonnet JC, Bellini WJ, Rota PA. Tamin A, et al. Among authors: lo mk. J Virol Methods. 2009 Sep;160(1-2):1-6. doi: 10.1016/j.jviromet.2009.02.025. Epub 2009 Mar 9. J Virol Methods. 2009. PMID: 19559943 Free PMC article.

5

Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISA.

Chiang CF, Lo MK, Rota PA, Spiropoulou CF, Rollin PE. Chiang CF, et al. Among authors: lo mk. Virol J. 2010 Jun 3;7:115. doi: 10.1186/1743-422X-7-115. Virol J. 2010. PMID: 20525276 Free PMC article.

6

Characterization of the antiviral and inflammatory responses against Nipah virus in endothelial cells and neurons.

Lo MK, Miller D, Aljofan M, Mungall BA, Rollin PE, Bellini WJ, Rota PA. Lo MK, et al. Virology. 2010 Aug 15;404(1):78-88. doi: 10.1016/j.virol.2010.05.005. Virology. 2010. PMID: 20552729 Free article.

7

Characterization of Nipah virus from outbreaks in Bangladesh, 2008-2010.

Lo MK, Lowe L, Hummel KB, Sazzad HM, Gurley ES, Hossain MJ, Luby SP, Miller DM, Comer JA, Rollin PE, Bellini WJ, Rota PA. Lo MK, et al. Emerg Infect Dis. 2012 Feb;18(2):248-55. doi: 10.3201/eid1802.111492. Emerg Infect Dis. 2012. PMID: 22304936 Free PMC article.

8

Distinct and overlapping roles of Nipah virus P gene products in modulating the human endothelial cell antiviral response.

Lo MK, Peeples ME, Bellini WJ, Nichol ST, Rota PA, Spiropoulou CF. Lo MK, et al. PLoS One. 2012;7(10):e47790. doi: 10.1371/journal.pone.0047790. Epub 2012 Oct 19. PLoS One. 2012. PMID: 23094089 Free PMC article.

9

Activation and cell death in human dendritic cells infected with Nipah virus.

Gupta M, Lo MK, Spiropoulou CF. Gupta M, et al. Among authors: lo mk. Virology. 2013 Jun 20;441(1):49-56. doi: 10.1016/j.virol.2013.03.004. Epub 2013 Apr 13. Virology. 2013. PMID: 23587249 Free article.

10

Single-dose replication-defective VSV-based Nipah virus vaccines provide protection from lethal challenge in Syrian hamsters.

Lo MK, Bird BH, Chattopadhyay A, Drew CP, Martin BE, Coleman JD, Rose JK, Nichol ST, Spiropoulou CF. Lo MK, et al. Antiviral Res. 2014 Jan;101:26-9. doi: 10.1016/j.antiviral.2013.10.012. Epub 2013 Oct 30. Antiviral Res. 2014. PMID: 24184127 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters